NCT06164535View on ClinicalTrials.gov

The Effects of DPPIs on Cognitive Function of Diabetic Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

December 30, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

July 15, 2024

Conditions
Cognitive Impairment
Interventions
DRUG

Control group

35 T2DM patients will be given placebo (only adjust their drugs to control blood glucose level)

DRUG

DPP-4 inhibitor group

35 T2DM patients will be given DPP-4 I once or twice daily

DRUG

DPP-4 inhibitor + metformin group

35 T2DM patients will be given DPP-4 I + metformin once or twice daily

Trial Locations (1)

82511

Minia University hospital, Minya

All Listed Sponsors
collaborator

Clinical Pharmacy Department, Faculty of Pharmacy, 6 October University

UNKNOWN

collaborator

Faculty of Medicine, Minia University

UNKNOWN

lead

Beni-Suef University

OTHER